Reports Q4 revenue $103.3M, consensus $97.81M. Bill Sibold, Chief Executive Officer of Madrigal, stated, “Looking back on 2024, I’m incredibly ...
WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Wednesday reported a loss of $59.4 million in its fourth quarter. The West Conshohocken, ...
In just the second day of Spring Training games, the New York Mets lost a key offseason acquisition, testing their infield ...
Madrigal Pharmaceuticals (MDGL) reported positive two-year results from the open-label compensated MASH cirrhosis arm of the Phase 3 ...
2h
Zacks.com on MSNMadrigal (MDGL) Reports Q4 Loss, Tops Revenue EstimatesMadrigal (MDGL) delivered earnings and revenue surprises of 34.22% and 1.69%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Nick Madrigal's injury opened a spot on the New York Mets Opening Day roster, and two of the organization's young prospects - ...
Nick Madrigal’s fractured left shoulder, which will knock him out for at least the first two months of the season, doesn’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results